Literature DB >> 21932149

[Microneurovascular facial reanimation via the masseteric nerve: reconstruction alternative for long-standing facial palsy].

S Dützmann1, G Marquardt, V Seifert, K G Krishnan.   

Abstract

BACKGROUND: The aim of the study was to retrospectively analyze the functional outcomes of microneurovascular facial reanimation using the masseteric innervation. PATIENTS AND METHODS: Seventeen patients with irreparable facial paralyses resulting from benign lesions involving the facial nuclei (n=14) or Möbius syndrome (n=3) were treated with free muscle flaps for oral commissural reanimation using ipsilateral masseteric innervation and using temporalis muscle transfer for eyelid reanimation. The results were analyzed by a commissural excursion (CE) index and a patient self-evaluation score. The presence of synkinesis was documented. Follow-up ranged from 8 to 48 months (mean 26.4 months).
RESULTS: Normalization of the CE index could be observed in 8 out of 17 patients (47%), an improvement in 7 out of 17 (41%) and failure in 2 out of 17 (12%). A natural smiling response was observed in 10 out of 17 (59%) patients. Patient self-evaluation scores were a level higher than objective indices.
CONCLUSIONS: Innervation of free muscle flaps with the masseteric nerve for oral commissure reanimation might play an important role in patients with long-standing facial palsy (as in Möbius syndrome). Synkinesis persists for long periods after surgery. However, most of the patients had learned to express their emotions by overcoming this phenomenon. Despite hypercorrection or inadequate correction, patients evaluate themselves favorably.

Entities:  

Mesh:

Year:  2011        PMID: 21932149     DOI: 10.1007/s00115-011-3300-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  11 in total

1.  Microsurgical Strategies in 74 Patients for Restoration of Dynamic Depressor Muscle Mechanism: A Neglected Target in Facial Reanimation.

Authors:  Ralph T. Manktelow
Journal:  Plast Reconstr Surg       Date:  2000-05       Impact factor: 4.730

2.  The three-stage concept to optimize the results of microsurgical reanimation of the paralyzed face.

Authors:  Manfred Frey; Pietro Giovanoli
Journal:  Clin Plast Surg       Date:  2002-10       Impact factor: 2.017

Review 3.  Muscle transplantation for reconstruction of a smile after facial paralysis past, present, and future.

Authors:  P J Guelinckx; N K Sinsel
Journal:  Microsurgery       Date:  1996       Impact factor: 2.425

4.  Prospective evaluation of eyelid function with gold weight implant and lower eyelid shortening for facial paralysis.

Authors:  D B Chepeha; J Yoo; C Birt; R W Gilbert; J Chen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-03

5.  One-stage transfer of the latissimus dorsi muscle for reanimation of a paralyzed face: a new alternative.

Authors:  K Harii; H Asato; K Yoshimura; Y Sugawara; T Nakatsuka; K Ueda
Journal:  Plast Reconstr Surg       Date:  1998-09       Impact factor: 4.730

6.  Psychological and social factors in reconstructive surgery for hemi-facial palsy.

Authors:  E T Bradbury; W Simons; R Sanders
Journal:  J Plast Reconstr Aesthet Surg       Date:  2006       Impact factor: 2.740

7.  Intracranial reconstruction of the facial nerve. Clinical observation.

Authors:  J Kanzaki; T Kunihiro; T O-Uchi; K Ogawa; R Shiobara; S Toya
Journal:  Acta Otolaryngol Suppl       Date:  1991

Review 8.  Nerve transfer with functioning free muscle transplantation.

Authors:  David Chwei-Chin Chuang
Journal:  Hand Clin       Date:  2008-11       Impact factor: 1.907

9.  Dynamic reconstruction of eye closure by muscle transposition or functional muscle transplantation in facial palsy.

Authors:  Manfred Frey; Pietro Giovanoli; Chieh-Han John Tzou; Nina Kropf; Susanne Friedl
Journal:  Plast Reconstr Surg       Date:  2004-09-15       Impact factor: 4.730

10.  Surgical results of the Hypoglossal-Facial nerve Jump Graft technique.

Authors:  L P Flores
Journal:  Acta Neurochir (Wien)       Date:  2007-11-05       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.